PHILADELPHIA, April 19 /PRNewswire/ -- The joint winners of the 2004
Wistar Institute Science Journalism Award are Sue Goetinck Ambrose, a science
writer for The Dallas Morning News, and W. Wayt Gibbs, senior writer for
Scientific American. The shared award and cash prize of $5,000 will be
presented to the two journalists at a ceremony in Philadelphia on June 4.
The judges chose to honor the two journalists for their coverage of
epigenetics, an emerging and still mysterious field of genetic research. The
judges were particularly impressed that on the 50th anniversary of the
discovery of the structure of DNA, the writers looked to the future of
genetics rather than dwelling on the historical importance of the earlier
The award is given jointly because the judges wanted to acknowledge the
parallel achievement of the writers for the clear and informative presentation
of epigenetics to a general audience by Ambrose and the sophisticated
treatment of the same topic by Gibbs for an audience interested in science.
The six members of the judges panel are: Deborah Blum (co-chair),
Professor of Journalism, University of Wisconsin-Madison, and 1992 Pulitzer
Prize winner; Joe Palca (co-chair), Senior Science Correspondent, National
Public Radio; Robert Bazell, Chief Science Correspondent, NBC News; Carol
Ezzell Webb, Freelance Journalist and Contributing Editor for Scientific
American; Usha Lee McFarling, Science Writer, Los Angeles Times; and Charles
Petit, Senior Writer, U.S. News & World Report.
The selection of the 2004 winners of the Wistar Institute Science
Journalism Award inaugurates this major new award in journalism that aims to
honor annually the most insightful and enterprising reporting on the basic
biomedical sciences in print or broadcast journalism during the award year.
The award acknowledges biomedical research as a key force for change in
the world today, with important economic and social implications for the
future. Intelligent, perceptive journalism written in broadly accessible
language plays a primary role in communicating progress in biomedicine to the
public, which both supports and is the beneficiary of basic biomedical
research. For these reasons, journalistic excellence in this area is of the
highest importance and deserves to be honored.
Science journalists working in all media are invited to submit their work
for consideration for the 2005 Wistar Institute Science Journalism Award. Up
to five stories or broadcast reports from an individual journalist or team of
journalists may be submitted as an entry. These may be selections from a
series or a collection of stories representative of the entrant's coverage of
the basic biomedical sciences. Books are not eligible. The work must have
been published or broadcast in English between January 1 and December 31,
2004. The deadline for submissions is February 28, 2005.
For more information about the award, please visit:
The 2004 Wistar Institute Science Journalism Award will be presented on
June 4 in Philadelphia in conjunction with a seminar for members of the
science media. The award presentation will take place at a luncheon event
during the day-long seminar. The seminar will offer a series of focused
briefings on recent shifts in scientific thinking concerning vaccines, while
also placing that information into a social, political, and economic context.
The presenters are leading vaccine researchers and public health officials who
will explore the science of vaccines and some of the vital framing issues
attending their distribution and use.
For more information about the media seminar and award ceremony planned
for June 4 in Philadelphia, please visit:
The Wistar Institute is an independent nonprofit biomedical research
institution dedicated to discovering the causes and cures for major diseases,
including cancer, cardiovascular disease, autoimmune disorders, and infectious
diseases. Founded in 1892 as the first institution of its kind in the nation,
The Wistar Institute today is a National Cancer Institute-designated Cancer
Center - one of only eight focused on basic research. Discoveries at Wistar
have led to the development of vaccines for such diseases as rabies and
rubella, the identification of genes associated with breast, lung, and
prostate cancer, and the development of monoclonal antibodies and other
significant research technologies and tools.
News releases from The Wistar Institute are available to reporters by
direct e-mail or fax upon request. They are also posted electronically to
Wistar's home page (http://www.wistar.upenn.edu), to EurekAlert!
(http://www.eurekalert.org), an Internet resource sponsored by the American
Association for the Advancement of Science, and to the public interest
newswire AScribe (http://www.ascribe.org).
SOURCE The Wistar Institute